ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.178,42
-0,14%
S&P 500
5.996,66
1,00%
US Dollar vs BRL
6,0791
-0,03%
Bitcoin
107.027,47
3,80%
Brent Oil
80,11
-0,13%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. United Therapeutics Corporation (UTHR)

  7. United Therapeutics Corporation (UTHR) Notícias

UTHR

United Therapeutics (UTHR)

United Therapeutics Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR
DataHoraFonteTítuloCódigoCompanhia
17/01/202518:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
13/01/202518:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
13/01/202510:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UTHRUnited Therapeutics Corporation
06/01/202509:00Business WireUnited Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
17/12/202409:00Business WireUnited Therapeutics Announces Successful World’s First UKidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
08/11/202418:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
05/11/202418:30Business WireUnited Therapeutics Corporation to Present at the UBS Global Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
30/10/202407:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UTHRUnited Therapeutics Corporation
30/10/202407:30Business WireUnited Therapeutics Corporation Reports Third Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
23/10/202408:00Business WireUnited Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion ServiceNASDAQ:UTHRUnited Therapeutics Corporation
23/10/202407:30Business WireUnited Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024NASDAQ:UTHRUnited Therapeutics Corporation
24/09/202408:00Business WireUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual MeetingNASDAQ:UTHRUnited Therapeutics Corporation
10/09/202408:00Business WireUnited Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—EverNASDAQ:UTHRUnited Therapeutics Corporation
28/08/202408:00Business WireUnited Therapeutics Corporation to Present at Upcoming Investor ConferencesNASDAQ:UTHRUnited Therapeutics Corporation
01/08/202411:54Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:UTHRUnited Therapeutics Corporation
31/07/202407:30Business WireUnited Therapeutics Corporation Reports Second Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
24/07/202408:00Business WireUnited Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024NASDAQ:UTHRUnited Therapeutics Corporation
10/07/202408:00Business WireUnited Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:UTHRUnited Therapeutics Corporation
27/06/202408:00Business WireUnited Therapeutics Corporation Announces Election of Jan Malcolm to its Board of DirectorsNASDAQ:UTHRUnited Therapeutics Corporation
05/06/202408:00Business WireUnited Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
31/05/202408:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:UTHRUnited Therapeutics Corporation
01/05/202407:30Business WireUnited Therapeutics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
26/04/202415:02Business WireCORRECTING and REPLACING PHOTO United Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202410:00Business WireUnited Therapeutics Announces World’s First Successful Xenothymokidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
24/04/202408:00Business WireUnited Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024NASDAQ:UTHRUnited Therapeutics Corporation
16/04/202408:00Business WireUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
26/03/202408:00Business WireUnited Therapeutics Announces the First Comprehensive Review Publication on XenotransplantationNASDAQ:UTHRUnited Therapeutics Corporation
25/03/202408:00Business WireUnited Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase ProgramNASDAQ:UTHRUnited Therapeutics Corporation
05/03/202408:00Business WireUnited Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024NASDAQ:UTHRUnited Therapeutics Corporation
27/02/202408:00Business WireUnited Therapeutics Corporation to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR

Seu Histórico Recente

BIT
NSCIT0082825
Euro Bk 0cnts28
OKEX
CTXCUSDT
Cortex
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados